{"id":"NCT00508742","sponsor":"Pfizer","briefTitle":"Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization","officialTitle":"A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization With Vaccine Serotypes of Streptococcus Pneumoniae in Healthy Infants in Israel.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2011-08","completion":"2011-08","firstPosted":"2007-07-30","resultsPosted":"2012-07-13","lastUpdate":"2013-05-10"},"enrollment":1866,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Infections"],"interventions":[{"type":"BIOLOGICAL","name":"13-valent Pneumococcal Conjugate Vaccine","otherNames":["13vPnC"]},{"type":"BIOLOGICAL","name":"7 valent pneumococcal conjugate vaccine","otherNames":["7vPnC"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"This study is designed to assess the impact of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) on nasopharyngeal colonization with Streptococcus pneumoniae in healthy infants.","primaryOutcome":{"measure":"Percentage of Participants With a New Acquisition of Serotype 6A' (6A + 6C) or 19A Combined 1 Month After the Infant Series to 24 Months of Age","timeFrame":"Month 7 through Month 24","effectByArm":[{"arm":"13vPnC","deltaMin":20,"sd":null},{"arm":"7vPnC","deltaMin":36,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"42 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":5,"countries":["Israel"]},"refs":{"pmids":["31995183","28087146","27422342","25355940","23804191"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=6096A1-3006&StudyName=Study%20Evaluating%20the%20Impact%20of%20a%2013-valent%20Pneumococcal%20Conjugate%20Vaccine%20on%20Nasopharyngeal%20Colonization"]},"adverseEventsSummary":{"seriousAny":{"events":64,"n":930},"commonTop":["Otitis media","Pyrexia","Pharyngitis","Pneumonia","Restlessness"]}}